El interés en corto de Jerash Holdings (US) da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Jerash Holdings (US). Los datos de interés en corto se actualizan cada dos semanas.

Jerash Holdings (US) (NASDAQ:JRSH) Bolsa, Informe de interés en corto

Jerash Holdings (US)

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Konskie,,Poland,-,January,31,,2024:,Factset,Company,Logo,Displayed

Pre-Market Outlook

AGMH

JRSH

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: FDS, CMC, AGMH, JRSH y KBH.

5 acciones en el foco este lunes: FDS, CMC, AGMH, JRSH y KBH

ABNB

BLAC

BSLK

CNSP

FFIE

INFA

MBRX

MYNA

PCLA

SLSR

STAI

STVN

VRPX

ZCAR

Airbnb supera expectativas de ingresos y sus acciones suben un 13,9% en premercado. Descubre qué otros valores están destacando hoy.

Acciones de Airbnb (ABNB) suben alrededor del 14%; 20 acciones que se mueven en el premercado de EE.UU.

Jerash Holdings (US), Inc. - Common Stock

Jerash Holdings (US) Inc

Keefe, Bruyette &amp; Woods analyst Bose George downgrades PennyMac Mortgage IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMT#NYSE">PMT</a>) from Outperform to Market Perform and lowers the price target from $14.5 to $13.5.

News

Downgrades

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Downgrades PennyMac Mortgage IT to Market Perform, Lowers Price Target to $13.5

The European Medicines Agency&#8217;s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) donanemab for early symptomatic Alzheimer&#8217;s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">heterozygotes or non-carriers</a>.
For more about the current price of LLY stock, <a href="https://www.benzinga.com/quote/LLY">click here.</a>
Donanemab, a monthly infusion, is currently marketed as Kisunla in&nbsp;the <a href="https://www.benzinga.com/pressreleases/25/07/n46625992/donanemab-receives-positive-opinion-from-the-committee-for-medicinal-products-for-human-use-chmp-i" target="_blank" rel="noreferrer noopener">U.S.&nbsp;and other countries</a>.
In&nbsp;the U.S.,&nbsp;Japan,&nbsp;China and many other countries, donanemab is approved for patients regardless of ApoE4 status.
Donanemab is the first and only amyloid plaque-targeting therapy with evidence to support stopping therapy when amyloid plaques are removed, which can result in lower treatment costs and fewer infusions.
The European Commission is expected to make a regulatory decision on donanemab in the coming months.
Also Read: <a href="https://www.benzinga.com/news/health-care/25/06/46173089/alzheimers-setback-hits-inmune-bio-stock-but-fda-hopes-remain" target="_blank" rel="noreferrer noopener">Alzheimer&#8217;s Setback Hits INmune Bio Stock, But FDA Hopes Remain</a>
Alzheimer&#8217;s disease currently affects as many as 6.9 million people in Europe,&nbsp;with this figure expected to almost double by 2050 as aging populations continue to increase.
Approximately one-third of individuals with mild cognitive impairment or mild dementia due to Alzheimer&#8217;s disease progress to the next clinical stage of disease in one year.
The positive opinion was primarily based on clinical trial data from the TRAILBLAZER-ALZ 2 clinical trial, which demonstrated that donanemab significantly slowed cognitive and functional decline and reduced the risk of progressing to the next clinical stage of disease, and the TRAILBLAZER-ALZ 6 clinical trial, which evaluated a modified titration dosing schedule.
In the TRAILBLAZER-ALZ 6 study, the modified titration schedule significantly lowered the incidence of amyloid-related imaging abnormalities with edema/effusion (ARIA-E) versus the dosing schedule used in TRAILBLAZER-ALZ 2 at 24 and 52 weeks, while still achieving similar levels of amyloid plaque removal and P-tau217 reduction
In July, the U.S. Food and Drug Administration <a target="_blank" href="https://www.benzinga.com/news/fda/25/07/46319441/fda-approves-new-dosing-schedule-for-eli-lillys-kisunla-in-alzheimers-treatment" rel="noreferrer noopener">approved a label update</a> with a new recommended titration dosing schedule for&nbsp;Kisunla.
The FDA approved the&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39620867/eli-lillys-alzheimers-therapys-broad-label-reflects-regulatory-confidence-in-anti-a" rel="noreferrer noopener">drug in July 2024</a>.
In the&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41608511/eli-lilly-says-new-data-can-potentially-provide-path-to-improved-donanemab-profile-by-lower-risk-" rel="noreferrer noopener">TRAILBLAZER-ALZ 6 study</a>, the modified titration schedule significantly reduced the incidence of ARIA-E compared to the original dosing schedule at 24 and 52 weeks, while achieving similar levels of amyloid plaque removal&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46314838/fda-approves-updated-label-for-lillys-kisunla-donanemab-azbt-with-new-dosing-in-early-symptomatic-" rel="noreferrer noopener">and P-tau217 reduction</a>.
In other news, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) agreed to acquire Vigil Neuroscience Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) for&nbsp;an <a href="https://www.benzinga.com/general/biotech/25/05/45561443/sanofi-boosts-alzheimers-pipeline-with-vigil-neuroscience-acquisition" target="_blank" rel="noreferrer noopener">approximately $470 million equity value</a>. The acquisition strengthens Sanofi's neurology pipeline with VG-3927, an oral TREM2 agonist for Alzheimer's disease.
LLY Price Action: Eli Lilly stock is up 0.42% at $805.77&nbsp;during the premarket session at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/07/46626902/chevron-set-to-restart-venezuela-oil-operations-after-trump-reversal" target="_blank" rel="noreferrer noopener">Chevron Set To Restart Venezuela Oil Operations After Trump Reversal</a></li>
</ul>
Photo: Shutterstock

Biotech

Eurozone

Health Care

General

VIGL

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

Charter Communications (NASDAQ: CHTR) stock declined after it released its <a href="https://www.benzinga.com/pressreleases/25/07/n46626616/charter-announces-second-quarter-2025-results" target="_blank" rel="noreferrer noopener">fiscal second-quarter</a> 2025 results on Friday. 
The company reported quarterly revenue growth of 0.6% year-on-year to $13.77 billion, beating the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate</a> of $13.76 billion.
Earnings per share of $9.18 missed the analyst consensus estimate of $9.80.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45502573/charters-proposed-cox-deal-could-challenge-comcast-surpass-att-in-broadband" target="_blank" rel="noreferrer noopener">Charter&#8217;s Proposed Cox Deal Could Challenge Comcast, Surpass AT&amp;T In Broadband</a>
The topline performance reflects revenue growth of 24.9% for residential mobile service, 2.8% for residential Internet, and 18.9% for other revenue.
Charter lost 117,000 internet customers, compared to a decline of 149,000 during the second-quarter of 2024 which included the impact of approximately 50,000 disconnects related to the end of the FCC&#8217;s Affordable Connectivity Program subsidies.
Charter&#8217;s residential video customers decreased by 80,000 compared to 408,000 in the previous year.
Charter&#8217;s mobile lines increased by 500,000 during the quarter, reaching 10.9 million as of June 30. AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) added 401,000 <a href="https://www.benzinga.com/markets/earnings/25/07/46570015/atts-discount-bundles-fuel-subscriber-gains-tax-savings-to-supercharge-fiber-expansion" target="_blank" rel="noreferrer noopener">postpaid phone customers</a> in the second quarter, down slightly from 419,000 last year but still strong. In contrast, Verizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) lost 9,000 postpaid phone connections, missing analyst expectations for a 13,000 gain.
Charter&#8217;s adjusted EBITDA margin remained flat at 41.4%.
The quarterly free cash flow of $1.1 billion decreased from $1.3 billion in the prior year, primarily driven by lower net cash flows from operating activities.
As of June 30, Charter served 29.9 million residential and small business Internet customers.
Net cash flow from operating activities totaled $3.6 billion during the quarter. As of June 30, the company held $606 million in cash and equivalents.
During the quarter, Charter purchased 4.5 million Charter and Charter Communications shares totaling&nbsp;$1.7 billion.
2025 Outlook: Charter Communications&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">expects a capex</a>&nbsp;of approximately&nbsp;$11.5 billion (<a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/45007666/charter-loses-internet-and-tv-subscribers-but-beats-rivals-with-strong-mobile-line-gains" rel="noreferrer noopener">prior $12 billion</a>) versus $11.27 billion&nbsp;in fiscal 2024. The decrease primarily reflects the timing of network evolution spending and lower commercial and subsidized rural line extensions spending.
Charter stock gained 11% year-to-date compared to the NASDAQ Composite Index&#8217;s (which includes the stock) over 9% returns.
Price Action: Charter Communications stock is down 10.6% to $339.61 in the premarket at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/45119505/t-mobiles-consistent-subscriber-growth-and-strong-market-trends-prompt-analyst-upgrade" target="_blank" rel="noreferrer noopener">T-Mobile Stock Gets A Lift As Subscriber Growth Holds Steady</a></li>
</ul>
Image: Shutterstock

Earnings

Guidance

CHTR

Charter Stock Slides Despite Revenue Beat—Mobile Gains Offset By Internet, Video Subscriber Losses

Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) posted better-than-expected second-quarter results after <a href="https://www.benzinga.com/quote/COUR">Thursday&#8217;s closing bell</a>.
Coursera reported quarterly earnings of 12 cents per share, which beat the analyst consensus estimate of nine cents. Quarterly revenue clocked in at $187.1 million, which beat the Street estimate of $180.48 million.
"Coursera's market opportunity continues to expand with the global demand to embrace new technology and skills. This quarter, we attracted more than seven million new learners looking to master emerging skills that can advance their careers," said Coursera CEO Greg Hart.
Coursera raised its full year 2025 revenue outlook by $17 million to a range of $738 to $746 million.
Coursera shares gained 1.3% to close at $9.08 on Thursday.
These analysts made changes to their price targets on Coursera following earnings announcement.
<ul class="wp-block-list">
<li>Needham analyst Ryan MacDonald maintained Coursera with a Buy and raised the price target from $11 to $14.</li>
<li>B of A Securities analyst Nafeesa Gupta upgraded Coursera from Underperform to Neutral and raised the price target from $7 to $12.</li>
<li>Telsey Advisory Group analyst Sarang Vora maintained the stock with an Outperform rating and raised the price target from $12 to $14.</li>
<li>Keybanc analyst Bradley Thomas maintained Coursera with an Overweight rating and boosted the price target from $11 to $12.</li>
<li>Morgan Stanley analyst Josh Baer maintained the stock with an Equal-Weight rating and raised the price target from $11 to $12.</li>
<li>Cantor Fitzgerald analyst Yi Fu Lee maintained the stock with an Overweight rating and lifted the price target from $10 to $13.</li>
</ul>
Considering buying COUR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/COUR/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25092239/image-402-1024x582.png" alt="" class="wp-image-1000792" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25092239/image-402-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25092239/image-402-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25092239/image-402-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/25092239/image-402.png 1138w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46599936/top-2-tech-stocks-you-may-want-to-dump-this-quarter">Top 2 Tech Stocks You May Want To Dump This Quarter</a></li>
</ul>
Photo via Shutterstock

Markets

Trading Ideas

COUR

Coursera Analysts Boost Their Forecasts After Upbeat Q2 Results

Keefe, Bruyette &amp; Woods analyst Bose George maintains Annaly Capital Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) with a Outperform and raises the price target from $20.5 to $21.5.

Keefe, Bruyette & Woods Maintains Outperform on Annaly Capital Management, Raises Price Target to $21.5

Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) (the "Company," "Volcon" or "Empery Digital") today announced that as of July 25th at 8:00am ET, the Company holds 3,183.37 BTC acquired for an aggregate purchase price of ~$375 million, reflecting an average purchase price of $117,697 per BTC. The Company has also sold various short-term put contracts giving the Company the opportunity to potentially buy additional BTC at $115,000, $116,000 and $117,000 while collecting option premium to reduce the cost of BTC. This aligns well with the Company's continued BTC acquisition strategy.
Additionally, the Company announced that its board of directors has authorized an increase in the current stock repurchase program. Volcon is now authorized to repurchase up to $100 million of the Company's outstanding shares of common stock, par value $0.00001, over the next 24 months. This repurchase program enables the Company the flexibility to support the NAV per share and potentially add BTC per share at share prices below NAV.
 &nbsp;

Buybacks

VLCN

Volcon Board Authorizes Stock Repurchase Of Up To $100M

Wells Fargo analyst Larry Biegelsen downgrades NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) from Overweight to Equal-Weight and lowers the price target from $40 to $14.5.

NVCR

Wells Fargo Downgrades NovoCure to Equal-Weight, Lowers Price Target to $14.5

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) with a Outperform and raises the price target from $103 to $104.

NDAQ

Keefe, Bruyette & Woods Maintains Outperform on Nasdaq, Raises Price Target to $104

Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) (the "Company," "Volcon" or "Empery Digital") today announced that as of July 25th at 8:00am ET, the Company holds 3,183.37 BTC acquired for an aggregate purchase price of ~$375 million, reflecting an average purchase price of $117,697 per BTC. The Company has also sold various short-term put contracts giving the Company the opportunity to potentially buy additional BTC at $115,000, $116,000 and $117,000 while collecting option premium to reduce the cost of BTC. This aligns well with the Company's continued BTC acquisition strategy.

Volcon Discloses $375M Bitcoin Holdings, Acquires 3,183.37 BTC At $117K Average Purchase Price

Cantor Fitzgerald analyst Sarah James downgrades Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) from Overweight to Neutral and lowers the price target from $312 to $210.

Cantor Fitzgerald Downgrades Molina Healthcare to Neutral, Lowers Price Target to $210

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates Live Oak Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOB#NYSE">LOB</a>) with a Market Perform and raises the price target from $36 to $37.

Reiteration

Keefe, Bruyette & Woods Reiterates Market Perform on Live Oak Bancshares, Raises Price Target to $37

Keefe, Bruyette &amp; Woods analyst Alex Bond maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Perform and raises the price target from $57 to $60.

Keefe, Bruyette & Woods Maintains Market Perform on Lazard, Raises Price Target to $60

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Ladder Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LADR#NYSE">LADR</a>) with a Outperform and raises the price target from $11.75 to $12.

LADR

Keefe, Bruyette & Woods Maintains Outperform on Ladder Capital, Raises Price Target to $12

<ul>
<li>INTC</li>
<li>UNH</li>
<li>TSLA</li>
<li>NVDA</li>
<li>$BTC</li>
<li>GLD</li>
<li>BULL</li>
<li>GOOGL</li>
<li>RKT</li>
<li>CORN</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

$BTC

BULL

CORN

GOOGL

INTC

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of July 25, 2025 (Via Swaggy Stocks)

WIIM

TROO

TROO stock has given up its prior gain. Troops shares were trading higher after the company initiated a stock repurchase agreement with an existing shareholder.

Keefe, Bruyette &amp; Woods analyst Woody Lay maintains John Marshall Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JMSB#NASDAQ">JMSB</a>) with a Outperform and raises the price target from $22 to $23.

JMSB

Keefe, Bruyette & Woods Maintains Outperform on John Marshall Bancorp, Raises Price Target to $23

Contracts

Diana Shipping Entered Into Time Charter Contract With Cargill Ocean Transportation For m/v DSI Phoenix; Gross Charter Rate $13,500 Minus 4.75% Commission Paid To Third Parties For Period Until Minimum Oct. 1, 2026 To Maximum Nov. 30, 2026

Rep.&nbsp;Marjorie Taylor Greene&nbsp;(R-Ga.) has expressed apprehensions about the environmental impact of President&nbsp;Donald Trump&#8216;s AI infrastructure plan.
What Happened: Greene, in a post on social media platform X, voiced concerns about the &#8220;massive&#8221; water usage of data centers on Thursday. She raised these concerns in response to Trump&#8217;s AI Action Plan, which was unveiled on Wednesday.
&#8220;Rushed&nbsp;AI expansion and data centers&nbsp;being built all over the&nbsp;country from state to state&nbsp;with no plan in regards&nbsp;to environmental and critical water&nbsp;supply impact has massive future&nbsp;implications and problems,&#8221; Greene said.
The AI Action Plan aims to exempt &#8220;data center-related actions&#8221; from environmental review and place data center and energy projects on fast-track under the nation&#8217;s permitting system. This could potentially lead to water quality impacts.
My deep concerns are that the EO demands rapid AI expansion with little to no guardrails and breaks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I have many concerns about the AI Executive Order signed yesterday by President Trump. While I understand the many promised benefits of AI, I remain committed to protecting state rights, human jobs, human lives, human rights, our environment and critical water supply. My deep…
&mdash; Rep. Marjorie Taylor Greene&#x1f1fa;&#x1f1f8; (@RepMTG) <a href="https://twitter.com/RepMTG/status/1948400163875152237?ref_src=twsrc%5Etfw">July 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Greene, who has a background in construction, highlighted the potential impact on the environment and water supply, emphasizing the need for a &#8220;careful and wise approach.&#8221;
She criticized the plan for rolling back AI regulations, especially at the state level, noting it would restrict federal funding to states with strict AI laws and task the FCC with reviewing whether those laws conflict with its authority.
Greene signed off saying &#8220;Competing with China does not mean become like China by threatening state rights, replacing human jobs on mass scale creating mass poverty, and creating potentially devastating effects on our environment and critical water supply.&#8221;
SEE ALSO: <a href="https://benzinga.com/news/topics/25/07/46602872/joe-rogan-says-most-americans-are-one-catastrophe-away-from-losing-everything-says-ai-and-ubi-income-" target="_blank" rel="noreferrer noopener">Joe Rogan Says Most Americans Are One Catastrophe Away From Losing Everything, Says AI And UBI Income Will Bring Chaos And Addiction</a>
Why It Matters: The AI Action Plan&#8217;s focus on fast-tracking data center construction and promoting American AI exports has been a topic of contention. President Trump&#8217;s signed the <a href="https://www.benzinga.com/markets/tech/25/07/46593182/trump-signs-new-executive-orders-to-fast-track-ai-dominance-we-will-be-unstoppable-as-a-nation">executive orders</a>, emphasizing the need for AI dominance and gain an edge over China. However, the environmental impact of these data centers has been a growing concern. 
<a href="https://www.benzinga.com/markets/tech/25/07/46487316/elon-musks-xai-unveils-sustainable-way-to-cool-memphis-data-center-amid-criticism-from-environmental-rights-groups">Elon Musk&#8217;s xAI</a> has faced backlash from environmental groups over its Memphis data center&#8217;s gas-burning turbine permit. The company later unveiled a &#8216;sustainable&#8217; way to cool its data center, but the controversy highlights the environmental challenges associated with AI infrastructure.
Against this backdrop, <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46610808/bloom-energy-stock-jumps-on-deal-to-power-oracles-ai-data-centers">companies like Bloom Energy</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) have been lauded for their sustainable power solutions for AI data centers. Shares of Bloom Energy Corp soared on Thursday, hitting a 52-week high following the announcement of a partnership with Oracle Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NASDAQ">ORCL</a>) Under the agreement, Bloom will deploy its proprietary fuel cell technology to supply onsite power for select Oracle Cloud Infrastructure data centers across the U.S.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46620387/marjorie-taylor-greene-increases-these-2-stocks-in-portfolio-including-this-ai-name-up-over-100-ytd">Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/news/politics/25/07/46620387/marjorie-taylor-greene-increases-these-2-stocks-in-portfolio-including-this-ai-name-up-over-100-ytd"> </a>

Politics

ORCL

Marjorie Taylor Greene Raises 'Deep Concerns' Over Environmental Devastation In Trump's AI Action Plan: 'Competing With China Does Not Mean...'

William Blair analyst Jeff Schmitt downgrades Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) from Outperform to Market Perform.

William Blair Downgrades Ameriprise Finl to Market Perform

Cantor Fitzgerald analyst Yi Fu Lee maintains Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) with a Overweight and raises the price target from $10 to $13.

Cantor Fitzgerald Maintains Overweight on Coursera, Raises Price Target to $13

Press Releases

Jerash Holdings to Report Financial Results for Fiscal 2025 Second Quarter on Tuesday, November 12, 2024

Dividends

Jerash Holdings (US), Inc. Declares Quarterly Dividend

Jerash Holdings Reports Financial Results for Fiscal 2025 Second Quarter

Jerash Holdings to Report Financial Results for Fiscal 2025 Third Quarter on Tuesday, February 11, 2025

Jerash Holdings Reports Fiscal 2025 Third Quarter Financial Results

Jerash Holdings to Report Financial Results for Fiscal 2025 Fourth Quarter and Full Year on Monday, June 23, 2025

Jerash Holdings Secures Major Initial Order for Large Multinational Retail Corporation Through New Strategic Collaboration  with South Korean Apparel Group, Hansoll Textile

Comments

Jerash Holdings (US)

Interés en corto

Jerash Holdings (US) (NASDAQ:JRSH) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL